PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.\', \'Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China.\', \'State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.\', \'State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: yibei.xiao@cpu.edu.cn.\', \'Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China. Electronic address: liyx417@fudan.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0006-291X(22)00377-110.1016/j.bbrc.2022.03.052
?:doi
?:hasPublicationType
?:journal
  • Biochemical and biophysical research communications
is ?:pmid of
?:pmid
?:pmid
  • 35303682
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 237
is ?:relation_isRelatedTo_publication of
?:title
  • Discovery of 4\'-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all